Prosecution Insights
Last updated: April 19, 2026
Application No. 17/304,194

NEAT REACTION PRODUCT OF CALCIUM AND VOLATILE FATTY ACIDS AS NUTRITIONAL SUPPLEMENT FOR LIVESTOCK AND POULTRY

Final Rejection §103
Filed
Jun 16, 2021
Examiner
GLIMM, CARRIE LYNN STOFFEL
Art Unit
1793
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Zinpro Corporation
OA Round
6 (Final)
22%
Grant Probability
At Risk
7-8
OA Rounds
3y 10m
To Grant
38%
With Interview

Examiner Intelligence

Grants only 22% of cases
22%
Career Allow Rate
15 granted / 68 resolved
-42.9% vs TC avg
Strong +16% interview lift
Without
With
+15.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 10m
Avg Prosecution
35 currently pending
Career history
103
Total Applications
across all art units

Statute-Specific Performance

§101
3.1%
-36.9% vs TC avg
§103
49.6%
+9.6% vs TC avg
§102
8.7%
-31.3% vs TC avg
§112
32.7%
-7.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 68 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of the Application Applicant's submission filed on 17 December 2025 has been entered. Claims 1-3 and 5-11 are pending. Claims 4 and 12 have been cancelled. The previous 112(b) rejections have been withdrawn in view of applicant’s amendments to the claims. The previous 103 rejections have been modified in view of applicant’s amendments to the claims. Claim Objections Claim 9 is objected to because of the following informalities: Claim 9, line 2: delete “source”. Appropriate correction is required. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-3, 6-10 are rejected under 35 U.S.C. 103 as being unpatentable over Vanderbilt (US Pat 4,804,547 Animal Feed Supplement Formulation, 1989). Regarding claim 1, Vanderbilt teaches methods for making an animal feed supplement comprising mixtures of calcium salts of certain volatile fatty acids (Col 1, line 11) where the calcium source is lime (95.4% calcium hydroxide) and the volatile fatty acids are isobutyric acid, 2-methylbutyric acid, valeric acid and isovaleric acid (Col 3, Example 1). Vanderbilt further teaches the mole ratio of calcium metal source (Ca) to low molecular weight volatile fatty acid source (FA) is 1:2 (See Table 1. below, source data from Vanderbilt Example 1, Col 3). PNG media_image1.png 200 400 media_image1.png Greyscale Vanderbilt’s Ca:FA ratio of 1:2 as seen above in Table 1, is considered close to the instantly claimed range of “1:1 to 1:1.9” Ca:FA. A prima facie case of obviousness exists where the claimed ranges or amounts do not overlap with the prior art but are merely close (MPEP 2144.05 I). Vanderbilt further teaches the only ingredients in the mixture are lime and the fatty acids (Col 3, Example 1), which meets the claim limitations “wherein the reaction is run neat”. Regarding the claim language that the process produces a product which “has a tolerable odor of less than 5,000 ppm fatty acids measured in the headspace of a sample,” and which is “substantially odor free”; since Vanderbilt teaches all of the process steps of claim 1 the resultant product is considered to be substantially odor free and have a tolerable odor of less than 5,000 ppm fatty acids measured in the headspace of a sample. Where the claimed and prior art products are identical or substantially identical in structure or composition, or are produced by identical or substantially identical processes, a prima facie case of either anticipation or obviousness has been established. In re Best, 562 F.2d 1252, 1255, 195 USPQ 430, 433 (CCPA 1977). "When the PTO shows a sound basis for believing that the products of the applicant and the prior art are the same, the applicant has the burden of showing that they are not." In re Spada, 911 F.2d 705, 709, 15 USPQ2d 1655, 1658 (Fed. Cir. 1990). Therefore, the prima facie case can be rebutted by evidence showing that the prior art products do not necessarily possess the characteristics of the claimed product. In re Best, 562 F.2d at 1255, 195 USPQ at 433. MPEP 2112.01 I. Regarding the claim limitation “calcium oxide and calcium hydroxide in the solid phase”, Vanderbilt discloses the lime is heated to 130 oC (Col 3, Example 1), while the melting point of calcium hydroxide is 580 oC and the melting point of calcium oxide is 2,613 oC. Since the melting point of calcium hydroxide and calcium oxide are above 130 oC, the calcium hydroxide and calcium oxide of Vanderbilt would have been in the solid phase. Regarding claim 2, Vanderbilt’s Ca:FA ratio of 1:2 as seen above in Table 1, is considered close to the instantly claimed range of “about 1:1.5 to 1:1.9” Ca:FA. A prima facie case of obviousness exists where the claimed ranges or amounts do not overlap with the prior art but are merely close (MPEP 2144.05 I). Regarding claim 3, Vanderbilt teaches the process takes place in a kettle equipped with an agitator (Col 3, Example 1), which meets the claim limitation of “a mechanical mix reactor”. Vanderbilt further teaches the only ingredients in the mixture are lime and the fatty acids (Col 3, Example 1), which meets the claim limitations of “without any fat encapsulating additive.” Regarding claim 10, Vanderbilt teaches the feed supplement is prepared in a resin kettle equipped with an agitator and addition funnel (Col 3, Example 1), which meets the claim limitation of “reacting is performed in a commercially available mixer.” Regarding claim 6, Vanderbilt teaches an animal feed supplement comprising mixtures of calcium salts of certain volatile fatty acids (Col 1, line 11) where the calcium source is lime (95.4% calcium hydroxide) and the volatile fatty acids are isobutyric acid, 2-methulbutyric acid, valeric acid and isovaleric acid (Col 3, Example 1). Vanderbilt further teaches the mole ratio of calcium metal source (Ca) to low molecular weight volatile fatty acid source (FA) is 1:2 (See Table 1. below, source data from Vanderbilt Example 1, Col 3). PNG media_image1.png 200 400 media_image1.png Greyscale Vanderbilt’s Ca:FA ratio of 1:2 as seen above in Table 1, is considered close to the instantly claimed range of “1:1 to 1:1.9” Ca:FA. A prima facie case of obviousness exists where the claimed ranges or amounts do not overlap with the prior art but are merely close (MPEP 2144.05 I). Vanderbilt further teaches the only ingredients in the mixture are lime and the fatty acids (Col 3, Example 1), which meets the claim limitations “wherein the reaction is run neat”. Regarding the claim language that the process produces a product which “has a tolerable odor of less than 5,000 ppm fatty acids measured in the headspace of a sample,” and which is “substantially odor free”; since Vanderbilt teaches all of the process steps of claim 1 the resultant product is considered to be substantially odor free and have a tolerable odor of less than 5,000 ppm fatty acids measured in the headspace of a sample for the same reasons as detailed in the claim 1 rejection above. Regarding the claim limitation “calcium oxide and calcium hydroxide in the solid phase”, Vanderbilt discloses the lime is heated to 130 oC (Col 3, Example 1), while the melting point of calcium hydroxide is 580 oC and the melting point of calcium oxide is 2,613 oC. Since the melting point of calcium hydroxide and calcium oxide are above 130 oC, the calcium hydroxide and calcium oxide of Vanderbilt would have been in the solid phase. Regarding claim 7, Vanderbilt’s Ca:FA ratio of 1:2 as seen above in Table 1, is considered close to the instantly claimed range of “1:1.5 to 1:1.9” Ca:FA. A prima facie case of obviousness exists where the claimed ranges or amounts do not overlap with the prior art but are merely close (MPEP 2144.05 I). Regarding claim 8, Vanderbilt teaches an animal feed supplement comprising mixtures of calcium salts of certain volatile fatty acids (Col 1, line 11) that can be fed to dairy cattle (Col 1, lines 25-27) where the calcium source is lime (95.4% calcium hydroxide) and the volatile fatty acids are isobutyric acid, 2-methulbutyric acid, valeric acid and isovaleric acid (Col 3, Example 1). Vanderbilt further teaches the mole ratio of calcium metal source (Ca) to low molecular weight volatile fatty acid source (FA) is 1:2 (See Table 1. below, source data from Vanderbilt Example 1, Col 3). PNG media_image1.png 200 400 media_image1.png Greyscale Vanderbilt’s Ca:FA ratio of 1:2 as seen above in Table 1, is considered close to the instantly claimed range of “1:1 to 1:1.9” Ca:FA. A prima facie case of obviousness exists where the claimed ranges or amounts do not overlap with the prior art but are merely close (MPEP 2144.05 I). Vanderbilt further teaches the only ingredients in the mixture are lime and the fatty acids and the product is a powder(Col 3, Example 1), which meets the claim limitations of “non-encapsulated” and “prepared neat”. Regarding the claim language that the product have “a tolerable odor of less than 5,000 ppm fatty acids measured in the headspace of a sample,” since Vanderbilt teaches all of the process steps of claim 8 the resultant product is considered to have a tolerable odor of less than 5,000 ppm fatty acids measured in the headspace of a sample for substantially the same reasons as detailed in the claim 1 rejection. Regarding claim 9, Vanderbilt’s Ca:FA ratio of 1:2 as seen above in Table 1, is considered close to the instantly claimed range of “1:1.5 to 1:1.9” Ca:FA. A prima facie case of obviousness exists where the claimed ranges or amounts do not overlap with the prior art but are merely close (MPEP 2144.05 I). Claims 5 and 11 are rejected under 35 U.S.C. 103 as being unpatentable over Vanderbilt as applied to claims 3 and 10 above, and further in view of Ingetecsa (https://web.archive.org/web/20210304222310/https://www.ingetecsa.com/machines/paddle-dryer/ March 2021). Regarding claim 5, Vanderbilt teaches the process of preparing the feed supplement of claim 3 as described above. Vanderbilt discloses the process in a resin kettle heated to 130 oC (Col 3, Example 1). Vanderbilt does not disclose the process run in a shear mechanical mixer with a paddle dryer system. Ingetecsa, also in the field of composition mixing and processing, discloses a paddle dryer system with high shear force where the paddles mix the contents in a radial direction (page 2, Paddle Design). The paddle dryer system allows for excellent temperature control and enables a uniform product quality (page 1, paragraph 2). It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to have combined the method of making a feed supplement of Vanderbilt with the paddle dryer of Ingetecsa in order to have excellent temperature control over the mixture and to provide a uniform product. Regarding claim 11, Vanderbilt teaches a resin kettle equipped with an agitator and addition funnel (Col 3, Example 1), which meets the claim limitation of “a commercially available mixer.” Vanderbilt further teaches the resin kettle is heated to 130 oC (Col 3, Example 1). Vanderbilt does not disclose the feed supplement prepared with a paddle dryer. Ingetecsa, also in the field of composition mixing and processing, discloses a paddle dryer system with high shear force where the paddles mix the contents in a radial direction (page 2, Paddle Design). The paddle dryer system allows for excellent temperature control and enables a uniform product quality (page 1, paragraph 2). It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to have combined the feed supplement of Vanderbilt with the paddle dryer of Ingetecsa in order to have excellent temperature control over the mixture and to provide a uniform product. Response to Arguments Applicant's arguments filed 17 December 2025 have been fully considered. To the extent they apply to the above rejection they are not persuasive. Applicant argues the composition of Vanderbilt relied upon by the office (Example 1) utilize 31.5% isobutyric acid and 68.5% a mixture of (36% 2-methylbutyric acid, 33% valeric, and 31 % isovaleric). Vanderbilt, Col. 3, lines 60-62. Applicant argues in all instances where isobutyric acid was included as a volatile fatty acid in Applicant's data, the headspace well-exceeded the claimed amount at Vanderbilt's ratio (Applicant points to Tables 1 and 2 in the specification). Similarly, where 2-methyl butyric acid was included as a volatile fatty acid Applicant's data, the headspace well-exceeded the claimed amount at Vanderbilt's ratio (Applicant points to Tables 4 and 5 in the specification). Applicant also points to Table 7 of the specification where a 1:8 ratio where 70% isobutyric acid and 30% 2-methylbutyric acid were employed the resultant headspace exceeded 10,000 ppm. Applicant asserts the evidence of record demonstrates that the compositions of Vanderbilt would not fall within the headspace requirements of the claims. Remarks pp7-8. This argument is not persuasive. Example 1 of Vanderbilt comprises a mixture of isobutyric acid (31.5 wt%), 2-methylbutyric acid (24.6 wt%), valeric acid (22.6 wt%) and isovaleric acid (21.2 wt%), which as can be seen in Table 1 above, provides a mole ratio of 1:2 of calcium metal source to low molecular weight volatile fatty acid. The data presented by the applicant (Tables 1, 2, 4 and 5 in the specification) are not directly comparable to the Example 1 of Vanderbilt. Tables 1 and 2 of the specification have a low molecular weight volatile fatty acid which is 100% isobutyric acid while Vanderbilt, Example 1, has a mixture of four different low molecular weight volatile fatty acids. Tables 4 and 5 of the specification have a low molecular weight volatile fatty acid which is 100% 2-methylbutyric acid while Vanderbilt, Example 1, has a mixture of four different low molecular weight volatile fatty acids. Table 7 of the specification has a mixture of two different low molecular weight volatile fatty acids, isobutyric (70%) and 2-methylbutyric (30%). The data showing that these compounds have a concentration of fatty acids in the headspace measuring more than 5000 ppm does not necessarily demonstrate that the compound of Vanderbilt, Example 1, will also have a concentration of fatty acids in the headspace measuring more than 5000 ppm. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to CARRIE GLIMM whose telephone number is (571)272-2839. The examiner can normally be reached Monday-Thursday 10:30-6:30 ET. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Emily Le can be reached at 571-272-0903. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Michele L Jacobson/Primary Examiner, Art Unit 1793 /C.L.G./Examiner, Art Unit 1793
Read full office action

Prosecution Timeline

Jun 16, 2021
Application Filed
Nov 15, 2022
Non-Final Rejection — §103
May 22, 2023
Response Filed
Aug 29, 2023
Final Rejection — §103
Dec 05, 2023
Request for Continued Examination
Dec 06, 2023
Response after Non-Final Action
Jun 05, 2024
Non-Final Rejection — §103
Sep 10, 2024
Response Filed
Oct 09, 2024
Final Rejection — §103
Feb 18, 2025
Request for Continued Examination
Feb 18, 2025
Response after Non-Final Action
Feb 20, 2025
Response after Non-Final Action
Sep 15, 2025
Non-Final Rejection — §103
Dec 17, 2025
Response Filed
Mar 09, 2026
Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12582141
Polypeptides Having Phytase Activity
2y 5m to grant Granted Mar 24, 2026
Patent 12543762
FREEZE DRIED WHOLE ANIMAL PET FOOD
2y 5m to grant Granted Feb 10, 2026
Patent 12527336
NOVEL PALATABILITY-ENHANCING COMPOSITION
2y 5m to grant Granted Jan 20, 2026
Patent 12507714
METHODS AND COMPOSITIONS FOR INCREASING KETONE BODIES IN ANIMALS
2y 5m to grant Granted Dec 30, 2025
Patent 12478080
DIRECT-FED MICROBIALS AND METHODS OF THEIR USE
2y 5m to grant Granted Nov 25, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

7-8
Expected OA Rounds
22%
Grant Probability
38%
With Interview (+15.7%)
3y 10m
Median Time to Grant
High
PTA Risk
Based on 68 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month